Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 28, 2009; 15(24): 2995-3002
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2995
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2995
Groups | TB | ALT | AST | Bun | Cr |
Control | 4.8 ± 1.67 | 41.5 ± 10.08 | 92.25 ± 46.81 | 3.3 ± 0.36 | 86.5 ± 6.19 |
Fe2O3 low dose | 8.025 ± 2.70 | 44.25 ± 16.35 | 87 ± 29.01 | 3 ± 0.99 | 83.25 ± 4.65 |
Fe2O3 high dose | 6.45 ± 2.97 | 34.5 ± 9.61 | 71.25 ± 35.64 | 2.475 ± 0.46 | 77.5 ± 15.44 |
As2O3/Fe2O3 | 7.93 ± 2.66 | 47.25 ± 14.19 | 52.75 ± 5.5 | 2.5 ± 0.25 | 92.25 ± 19.69 |
- Citation: Wang ZY, Song J, Zhang DS. Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells. World J Gastroenterol 2009; 15(24): 2995-3002
- URL: https://www.wjgnet.com/1007-9327/full/v15/i24/2995.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2995